UBE2B and Miyoshi myopathy: Given that we have not screened any clinical or pre-clinical drugs that are strongly related to UPPGs in CellMiner database, TZ9, a UBE2B-inhibitor, was found to inhibit the growth of MM cell lines in vitro experiment, which provided a new insight regarding the treatment of relapsed MM patients.